RecruitingPhase 4NCT06777758

Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments

The Comparison of Remimazolam or Propofol Used Alone Versus in Combination for Moderate Sedation During Endoscopic Examination and Treatment.


Sponsor

Kaohsiung Veterans General Hospital.

Enrollment

90 participants

Start Date

Feb 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.


Eligibility

Min Age: 20 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two sedation medications — remimazolam and propofol — used to keep patients comfortable and relaxed during upper digestive tract (upper GI) endoscopy procedures. Researchers want to find out which medication is safer, works better, and causes fewer side effects during these routine procedures. **You may be eligible if...** - You are between 20 and 80 years old - You are scheduled for an upper GI endoscopy (such as a gastroscopy) - Your overall health is rated as acceptable for sedation by an anesthesiologist (ASA class I–III) **You may NOT be eligible if...** - You are allergic to propofol, remimazolam, or opioid pain medications - It is an emergency procedure - You are pregnant - You have a history of malignant hyperthermia (a rare reaction to anesthesia) - You have liver or kidney problems - You have throat or airway problems that complicate sedation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRemimazolam

Remimazolam

DRUGPropofol

Propofol dose reduction ratio


Locations(1)

Kaohsiung Veterans General Hospital

Kaohsiung City, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06777758


Related Trials